Nanomedicine Characterization & Optimization

Connecting carrier properties with delivery performance

Nanomedicine development requires more than producing particles of a particular size. Particle composition, size distribution, surface properties, cargo association, stability and interactions with biological systems can all influence performance.

At Peptide Intelligence Consulting, we help researchers organize characterization strategies, interpret available data and investigate the relationships between formulation properties and delivery outcomes.

The scientific challenge

A nanoparticle formulation may appear physically consistent while showing variable cargo delivery or biological activity. Conversely, an observed change in performance may arise from several factors, making it difficult to identify the main cause.

A structured characterization strategy helps determine which properties have been measured, what the results support and which questions remain unresolved.

What we can help with

Physicochemical characterization strategy

• Identify appropriate measurements for particle size, size distribution and surface properties.

• Consider methods for assessing cargo association, encapsulation and release.

• Develop a characterization plan suited to the carrier and research objective.

Formulation comparison

• Compare candidate formulations against predefined criteria.

• Examine how changes in composition or processing may influence measured properties.

• Identify useful controls and sources of variability.

Stability and reproducibility

• Identify relevant conditions for assessing colloidal and cargo stability.

• Consider the influence of storage, buffer composition and environmental changes.

• Develop a plan for tracking formulation consistency over time.

Connecting characterization with function

• Help interpret physicochemical data alongside cellular uptake or functional delivery results.

• Investigate possible explanations for differences between particle properties and biological performance.

• Prioritize experiments that distinguish competing hypotheses.

Our approach

We begin by defining the delivery objective and reviewing the available formulation and characterization data. We then identify the most important performance criteria, evaluate whether the existing measurements address them and recommend further analyses where needed.

Depending on the project, relevant methods may include dynamic light scattering, zeta potential measurements, microscopy, cargo encapsulation assays, stability studies and application-specific biological assays.

No single measurement establishes overall nanomedicine quality. The interpretation depends on the formulation, the intended application and the evidence provided by complementary methods.

Potential applications

• Lipid nanoparticle and liposome research

• Peptide-functionalized nanocarriers

• Nucleic acid delivery formulations

• Formulation screening and comparison

• Early-stage nanomedicine development

• Investigations of delivery-system variability

What you can expect

Project outputs may include a characterization plan, a comparison of candidate formulations, an interpretation of existing data, identification of potential sources of variability and recommendations for the next optimization experiments.

Discuss your nanomedicine project

If you are evaluating a nanocarrier formulation or investigating why its physicochemical properties do not translate into the expected delivery performance, we can help you develop a focused evaluation strategy.

Contact Peptide Intelligence Consulting to discuss your project.